Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China

Author:

Yang-Li Dai,Fei-Hong Luo,Hui-Wen Zhang,Ming-Sheng Ma,Xiao-Ping Luo,Li Liu,Yi Wang,Qing Zhou,Yong-Hui Jiang,Chao-Chun ZouORCID,Xiao-Ou Shan,Yu Yang,Hui-Feng Zhang,Zhi-Liang Tian,Bo Sun,Mei Lu,Ya-Ying Cheng,Ying Yang,Xiong-Ying Yu,Jing Zhang,Xiao-Hong Chen,Fan Yang,Hong-Wei Ma,Maimaiti MireguIi,Gai-Xiu Zhang,Xiao-Hong Chen,Gui-Mie Li,Fan Tong,Ming-Qiang Zhi,Qiong Zhou,Yuan Gao,Kan Wang,Xiao-Ming Ying,Jian-Ping Zhang,Chun-Lin Wang,Chun-Ming Jiang,Rui Xiao, ,

Abstract

AbstractPrader-Willi syndrome (PWS) is a complex and multisystem neurobehavioral disease, which is caused by the lack of expression of paternally inherited imprinted genes on chromosome15q11.2-q13.1. The clinical manifestations of PWS vary with age. It is characterized by severe hypotonia with poor suck and feeding difficulties in the early infancy, followed by overeating in late infancy or early childhood and progressive development of morbid obesity unless the diet is externally controlled. Compared to Western PWS patients, Chinese patients have a higher ratio of deletion type. Although some rare disease networks, including PWS Cooperation Group of Rare Diseases Branch of Chinese Pediatric Society, Zhejiang Expert Group for PWS, were established recently, misdiagnosis, missed diagnosis and inappropriate intervention were usually noted in China. Therefore, there is an urgent need for an integrated multidisciplinary approach to facilitate early diagnosis and optimize management to improve quality of life, prevent complications, and prolong life expectancy. Our purpose is to evaluate the current literature and evidences on diagnosis and management of PWS in order to provide evidence-based guidelines for this disease, specially from China.

Funder

Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents

Zhejiang Provincial Department of Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3